Overview
May Counsilman is a General Surgeon and an Oncologist in Philadelphia, Pennsylvania. Dr. Counsilman is rated as an Experienced provider by MediFind in the treatment of Obstructive Uropathy. Her top areas of expertise are UPJ Obstruction, Urinary Tract Infection in Children, Urinary Tract Infection (UTI), Obstructive Uropathy, and Ureteroscopy. Dr. Counsilman is currently accepting new patients.
Her clinical research consists of co-authoring 2 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- MEDICARE PDP
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- MEDICARE MAPD
- OTHER MEDICARE
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- HMO
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- MANAGED MEDICAID PLAN
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
3998 Red Lion Road, Suite 305, Philadelphia, PA 19114
Additional Areas of Focus
Dr. Counsilman has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Jefferson Urology – Honickman Center
Scott Hubosky is an Urologist in Philadelphia, Pennsylvania. Dr. Hubosky is rated as an Elite provider by MediFind in the treatment of Obstructive Uropathy. His top areas of expertise are Upper Tract Urothelial Carcinoma (UTUC), Urothelial Cancer, Kidney Stones, Ureteroscopy, and Endoscopy. Dr. Hubosky is currently accepting new patients.
Trinity Health Mid-Atlantic Medical Group
Justin Harmon is an Urologist and a General Surgeon in Langhorne, Pennsylvania. Dr. Harmon is rated as a Distinguished provider by MediFind in the treatment of Obstructive Uropathy. His top areas of expertise are Obstructive Uropathy, Perirenal Abscess, Boils, Ureteroscopy, and Prostatectomy.
Summit Medical Group PA
Michael Bernstein is an Urologist in Berkeley Heights, New Jersey. Dr. Bernstein is rated as a Distinguished provider by MediFind in the treatment of Obstructive Uropathy. His top areas of expertise are Hydronephrosis, Bilateral Hydronephrosis, Obstructive Uropathy, Ureteroscopy, and Prostatectomy. Dr. Bernstein is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Acute CystitisDr. Counsilman isExperienced. Learn about Acute Cystitis.
- Bilateral HydronephrosisDr. Counsilman isExperienced. Learn about Bilateral Hydronephrosis.
- Bladder CancerDr. Counsilman isExperienced. Learn about Bladder Cancer.
- BoilsDr. Counsilman isExperienced. Learn about Boils.
- CarbuncleDr. Counsilman isExperienced. Learn about Carbuncle.
- Chromophobe Renal Cell CarcinomaDr. Counsilman isExperienced. Learn about Chromophobe Renal Cell Carcinoma.